QualityStocksNewsBreaks Archives - Page 746 of 1498

WednesdayMay 19, 2021 11:10 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Announces New Facility to House Indoor Plant Operations

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has a new warehouse located in Squamish, British Columbia. The new warehouse is a critical pieces of the company's expansion plans and will play a key supply chain role in the company’s distribution of indoor plants in Canada. With the global indoor plant market forecast to see a 10.24% growth rate and reach $7.2 million by 2026, PlantX is committed to its indoor plant vertical. The facility is a 3,000-square-foot, fully operational warehouse and will be co-managed by PlantX and Nootka & Sea, a privately held company operating in the apothecary and cosmetics space. PlantX…

WednesdayMay 19, 2021 10:24 am

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Announces On-Track Progress for Demonstration of i/Blue Imaging System(TM)

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging. Per the update, the company is on target to demonstrate the i/Blue Imaging System(TM) in private meetings during the American Urology Association (“AUA”) meeting to be held in early September. The product will showcase updates to meet performance criteria against competitive products and enhancements made to the design for manufacturing. “As the process moves forward, we’re creating the potential for additional IP that will…

WednesdayMay 19, 2021 9:56 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Patient Enrollment in Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has begun open enrollment for its upcoming study focused on analyzing the efficacy and safety of Berubicin in the treatment of adult recurrent Glioblastoma Multiforme (“GBM”). GMB is one of the most aggressive types of brain cancer, and Berubicin, which is in development for the treatment of several serious brain and CNS oncology indications, is the first anthracycline to cross the blood-brain barrier. CNSP plans on enrolling some 210 subjects across 35 clinical sites…

WednesdayMay 19, 2021 9:34 am

QualityStocksNewsBreaks – SRAX (NASDAQ: SRAX) Releases Q1 Revenue Growth, Increases Full-Year Guidance

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (”SaaS”) platform, posted a video on YouTube featuring founder and CEO Christopher Miglino along with CFO Michael Malone outlining the company’s operational and financial summary for Q1 2021. Highlights of the company’s financial report included the announcements that year-over-year revenue growth for the company was up 1,400%, with growth for Sequire alone up 2,800%; the company also increased its guidance for the year. Technology highlights from the report included the launch of the Sequire audience platform, where companies can host…

WednesdayMay 19, 2021 9:30 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Resurgent Growth, Strong Q1 2021 Results

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other industries, today announced its best financial results in nearly three years for the first quarter ended March 31, 2021. Among the highlights, the company reported a 121% increase in total revenue for Q1 2021 to $559,900 compared to $253,900 for Q1 2020. “We had a remarkable first quarter. Sales increased across the board — in instruments, consumables and kits. Importantly, we saw a concomitant decline in operating loss,” said Richard T.…

TuesdayMay 18, 2021 3:28 pm

QualityStocksNewsBreaks – Why StorEn Technologies Inc. Is ‘One to Watch’

StorEn Technologies delivers proprietary vanadium flow batteries designed to revolutionize residential and industrial energy storage capabilities. “With an expected life of 25 years and more than 15,000 cycles, the company’s batteries satisfy market demand for efficient, durable and cost-effective energy storage, enabling self-consumption of self-produced electricity and the transition toward a carbon-free economy,” reads a recent article about the company. “StorEn’s growing intellectual property portfolio currently features four international PCT patents and five trademarks, securing its innovative IP in all major regions and countries in the world.” To view the full article, visit https://ibn.fm/EWdCC About StorEn Technologies Inc. StorEn has…

TuesdayMay 18, 2021 3:20 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd. Leverages Optimal ‘Launch Pad’ for Intro to Brazilian Community

Mobius Interactive, an online esports and gaming operator, recently announced its expansion into the Brazilian market. According to the company, the Mobius.Bet brand will be displayed prominently for all eight World Cup qualifiers in Latin America. Soccer is the world’s biggest sport, and Brazil is a soccer powerhouse that holds more World Cup victories than any other team. “As we go to market in Brazil with this great opportunity, Mobius.Bet will be showcased on Globo TV and in every stadium, featuring the best teams in Latin America,” Mobius Interactive CEO Lynn Pearce was quoted in a recent update. “I don’t…

TuesdayMay 18, 2021 3:13 pm

QualityStocksNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics CTO Discusses Revolutionizing Drug Discovery in Bell2Bell Podcast

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, was featured in a recent episode of The Bell2Bell Podcast. Predictive Oncology’s newly appointed CEO Mel Engle, CFO Bob Myers and Mark Collins, chief technical officer of the company’s Helomics subsidiary, joined the program to share financial updates, future goals and insight into current operations. The discussion also highlighted Helomics’ innovative PeDAL (patient-centric drug discovery using active learning) platform. A unique technology, PeDAL combines a proprietary, clinically validated patient tumor cell line assay with a vast knowledge base of proprietary and…

TuesdayMay 18, 2021 2:59 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Eyes ‘Exceptional’ Work to Move i/Blue Imaging System(TM) into Commercial Manufacturing

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, was featured in a recent article that discussed its timely progress toward 2022 completion of its innovative i/Blue Imaging System(TM). The patented system is designed leveraging proprietary light sensors and optics to improve the efficiency and accuracy of bladder cancer visualization and removal. According to the update, the on-track progress can be largely attributed to the company’s selection of Lighthouse Imaging as its manufacturing partner. “Lighthouse’s development program is focused on refining the i/Blue system’s design to ensure that the final device complies with all regulatory standards while maintaining optimal…

TuesdayMay 18, 2021 2:16 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces A88CBD Partnership with Barstool Sports

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, has teamed up again with Barstool Sports, a series of network podcasts. As part of the brand partnership, WTER’s A88CBD(TM) line will be featured on eight network podcasts, including Short Porch and Section 10; the brand will also be featured on the social media accounts related to the respective podcasts. WTER’s A88CBD brand sources, produces and refines industry-leading CBD (“CBD”) (cannabidiol) commodities designed to enrich the daily wellness routines of their customers. WTER is committed to creating quality, hemp-derived CBD products, with CBD sourced from…

Site Search

Company Search

Category: QualityStocksNewsBreaks